Literature DB >> 29203292

Pitfalls in the detection of citrullination and carbamylation.

M K Verheul1, P A van Veelen2, M A M van Delft3, A de Ru2, G M C Janssen2, T Rispens4, R E M Toes3, L A Trouw5.   

Abstract

Carbamylation and citrullination are both post-translational modifications against which (auto)antibodies can be detected in sera of rheumatoid arthritis (RA) patients. Carbamylation is the chemical modification of a lysine into a homocitrulline, whereas citrullination is an enzymatic conversion of an arginine into a citrulline. It is difficult to distinguish between the two resulting amino acids due to similarities in structure. However, differentiation between citrulline and homocitrulline is important to understand the antigens that induce antibody production and to determine which modified antigens are present in target tissues. We have observed in literature that conclusions are frequently drawn regarding the citrullination or carbamylation of proteins based on reagents that are not able to distinguish between these two modifications. Therefore, we have analyzed a wide spectrum of methods and describe here which method we consider most optimal to distinguish between citrulline and homocitrulline. We have produced several carbamylated and citrullinated proteins and investigated the specificity of (commercial) antibodies by both ELISA and western blot. Furthermore, detection methods based on chemical modifications, such as the anti-modified citrulline-"Senshu" method and also mass spectrometry were investigated for their capacity to distinguish between carbamylation and citrullination. We observed that some antibodies are able to distinguish between carbamylation and citrullination, but an overlap in reactivity is often present in the commercially available anti-citrulline antibodies. Finally, we conclude that the use of mass spectrometry is currently essential to differentiate between citrullinated and carbamylated proteins present in complex biological samples.
Copyright © 2017 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-carbamylated protein antibodies; Anti-citrullinated protein antibodies; Carbamylation; Citrullination; Mass spectrometry; Rheumatoid arthritis

Mesh:

Substances:

Year:  2017        PMID: 29203292     DOI: 10.1016/j.autrev.2017.11.017

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  14 in total

1.  Citrullinome of Porphyromonas gingivalis Outer Membrane Vesicles: Confident Identification of Citrullinated Peptides.

Authors:  Daniel Nyberg Larsen; Christian Engelbrecht Mikkelsen; Mads Kierkegaard; Grzegorz P Bereta; Zuzanna Nowakowska; Jakub Z Kaczmarek; Jan Potempa; Peter Højrup
Journal:  Mol Cell Proteomics       Date:  2019-11-21       Impact factor: 5.911

2.  12-Plex DiLeu Isobaric Labeling Enabled High-Throughput Investigation of Citrullination Alterations in the DNA Damage Response.

Authors:  Zihui Li; Bin Wang; Qinying Yu; Yatao Shi; Lingjun Li
Journal:  Anal Chem       Date:  2022-02-07       Impact factor: 8.008

Review 3.  Proteomics in Chronic Arthritis-Will We Finally Have Useful Biomarkers?

Authors:  Christoph Kessel; Angela McArdle; Emely Verweyen; Toni Weinhage; Helmut Wittkowski; Stephen R Pennington; Dirk Foell
Journal:  Curr Rheumatol Rep       Date:  2018-07-14       Impact factor: 4.592

Review 4.  Insights into the study and origin of the citrullinome in rheumatoid arthritis.

Authors:  Justyna Fert-Bober; Erika Darrah; Felipe Andrade
Journal:  Immunol Rev       Date:  2019-12-25       Impact factor: 12.988

5.  Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations.

Authors:  Rory C Monahan; Michelle D van den Beukel; Nicole V Borggreven; Rolf Fronczek; Tom W J Huizinga; Margreet Kloppenburg; Gerda M Steup-Beekman; Leendert A Trouw
Journal:  RMD Open       Date:  2022-04

6.  Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients.

Authors:  Roberto Lande; Raffaella Palazzo; Philippe Hammel; Immacolata Pietraforte; Isabelle Surbeck; Michel Gilliet; Carlo Chizzolini; Loredana Frasca
Journal:  Antibodies (Basel)       Date:  2020-05-11

7.  Carbamylation reduces the capacity of IgG for hexamerization and complement activation.

Authors:  R Lubbers; S C Oostindie; D J Dijkstra; P W H I Parren; M K Verheul; L Abendstein; T H Sharp; A de Ru; G M C Janssen; P A van Veelen; E T J van den Bremer; B Bleijlevens; B-J de Kreuk; F J Beurskens; L A Trouw
Journal:  Clin Exp Immunol       Date:  2020-01-05       Impact factor: 4.330

Review 8.  Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology.

Authors:  Mikhail Volkov; Karin Anna van Schie; Diane van der Woude
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

9.  Phage-Display-Derived Peptide Specific to Carbamylated Protein.

Authors:  Yuhao Ma; Meng Wu; Shuhui Li; Marcello Tonelli; Larry D Unsworth
Journal:  ACS Omega       Date:  2021-01-25

Review 10.  Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.

Authors:  Mei-Ling Yang; Fernanda M C Sodré; Mark J Mamula; Lut Overbergh
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.